Диссертация (1140740), страница 21
Текст из файла (страница 21)
J Periodontol. 2009;80:541–9. [PubMed]151. Loo WT, Wang M, Jin LJ, Cheung MN, Li GR. Association of matrixmetalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 genepolymorphisms and their proteins with chronic periodontitis. Arch Oral Biol.2011 Oct;56(10):1081-90. doi: 10.1016/j.archoralbio.2011.03.011. Epub 2011Apr 11.144152. Loos BG Systemic markers of inflammation in periodontitis. J Periodontol.2005 Nov; 76(11 Suppl):2106-15.153. López NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, López R Effectsof periodontal therapy on systemic markers of inflammation in patients withmetabolic syndrome: a controlled clinical trial. J Periodontol.
2012 Mar;83(3):267-78154. Lundin M, Yucel-Lindberg T, Dahllöf G, Marcus C, Modéer T Correlationbetween TNFalpha in gingival crevicular fluid and body mass index in obesesubjects. Acta Odontol Scand. 2004 Oct; 62(5):273-7155. Maedler K, Dharmadhikari G, Schumann DM, Størling J.
Interleukin-targetedtherapy for metabolic syndrome and type 2 diabetes. Handb Exp Pharmacol.2011;(203):257-78. doi: 10.1007/978-3-642-17214-4_11.156. Meigs JB, Wilson PW, Nathan DM. Prevalence and Characteristics of theMetabolic Syndrome in the San Antonio Heart and Framingham OffspringStudies. Diabetes. 2003; (52):2160–7157. Mercanoglu F, Oflaz H, Oz O et al. Endothelial dysfunction in patients withchronic periodontitis and its improvement after initial periodontal therapy. JPeriodontol 2004; 75: 1694–1700.158.
Mirhafez SR, Pasdar A, Avan A, Esmaily H, Moezzi A, Mohebati M,Meshkat Z, Mehrad-Majd H, Eslami S, Rahimi HR, Ghazavi H, Ferns GA,Ghayour-Mobarhan M. Cytokine and growth factor profiling in patients withthe metabolic syndrome. Br J Nutr. 2015 Jun 28;113(12):1911-9. doi:10.1017/S0007114515001038. Epub 2015 May 20.159. Moebus S, Stang A.
The metabolic syndrome — a controversial diagnosticconcept. Herz. 2007;32 (7):529–40160. Morita T, Ogawa Y, Takada K, Nishinoue N, Sasaki Y, Motohashi M, et al.Association between periodontal disease and metabolic syndrome. J PublicHealth Dent.
2009;69:248–53. [PubMed];161. Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N, et al. Acohort study on the association between periodontal disease and the145development of metabolic syndrome. J Periodontol. 2010;81:512–9.[PubMed].162. Nakarai H, Yamashita A, Takagi M, Adachi M, Sugiyama M, Noda H,Katano M, Yamakawa R, Nakayama K, Takumiya H, Nakai Y, Taniguchi A,Nishimura F Periodontal disease and hypertriglyceridemia in Japanesesubjects: potential association with enhanced lipolysis. Metabolism. 2011 Jun;60(6):823-9.163. Nesbitt MJ, Reynolds MA, Shiau H, Choe K, Simonsick EM, Ferrucci L.Association of periodontitis and metabolic syndrome in the BaltimoreLongitudinal Study of Aging. Aging Clin Exp Res. 2010;22:238–42.
[PMCfree article] [PubMed]164. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS Severeperiodontitis is associated with systemic inflammation and a dysmetabolicstatus: a case-control study. J Clin Periodontol. 2007 Nov; 34(11):931-7165. Nibali L, Fedele S, D'Aiuto F, Donos N Interleukin-6 in oral diseases: areview. Oral Dis. 2012 Apr; 18(3):236-43166. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG. Cytokine genepolymorphisms in periodontal disease: a meta-analysis of 53 studies including4178 cases and 4590 controls. J Clin Periodontol. 2008 Sep;35(9):754-67.doi: 10.1111/j.1600-051X.2008.01298.x.
Epub 2008 Jul 31167. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y Periodontal diseaseas part of the insulin resistance syndrome in diabetic patients. J Int AcadPeriodontol. 2005 Jan; 7(1):16-20168. Nitta, H.; Katagiri, S.; Nagasawa, T.; Izumi, Y.; Ishikawa, I.; Izumiyama, H.;Uchimura, I.; Kanazawa, M.;Chiba, H.; Matsuo, A.; et al. The number ofmicrovascular complications is associated with an increased risk for severityof periodontitis in type 2 diabetic patients: Results of a multicenter hospitalbased cross-sectional study. J.
Diabetes Investig. 2017146169. Norderyd O, Hugoson A, Grusovin G. Risk of severe periodontal disease in aSwedish adult population. A longitudinal study. J Clin Periodontol.1999;26:608–615.170. Offenbacher S, et al. Results from the Periodontitis and Vascular Events(PAVE) Study: a pilot multicentered, randomized, controlled trial to studyeffects of periodontal therapy in a secondary prevention model ofcardiovasculardisease.J.Periodontol.2009;80:190–201.[PubMed:19186958]171. Oh H, Hirano J, Takai H, Ogata Y.
Effects of initial periodontal therapy oninterleukin-1β level in gingival crevicular fluid and clinical periodontalparameters. J Oral Sci. 2015 Jun;57(2):67-71. doi: 10.2334/josnusd.57.67172. Oh JY, Hong YS, Sung YA, Barrett-Connor E Prevalence and factor analysisof metabolic syndrome in an urban Korean population. Diabetes Care. 2004Aug;27(8):2027-32.;173. Page RC The role of inflammatory mediators in the pathogenesis ofperiodontal disease. J Periodontal Res. 1991 May; 26(3 Pt 2):230-42174. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB.The metabolic syndrome: prevalence and associated risk factor findings in theUS population from the Third National Health and Nutrition ExaminationSurvey, 1988–1994.
Arch Intern Med. 2003;163(4):427-36.175. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P,Febbraio M, Saltin B Searching for the exercise factor: is IL-6 a candidate? JMuscle Res Cell Motil. 2003; 24(2-3):113-9176. Polak D., Wilensky A., Shapira L. et al. Mouse model of experimentalperiodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatuminfection: bone loss and host response // J.
Clin. Periodontol. – 2009. – Vol.36, № 5. – P.406-410.177. Pradeep AR, Roopa Y, Swati PP.. Interleukin-4, a T-helper 2 cell cytokine, isassociated with the remission of periodontal disease. J Periodontal Res. 2008Dec;43(6):712-6. doi: 10.1111/j.1600-0765.2007.01079.x. Epub 2008 Jun 25.147178. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K,Taylor R.
Periodontitis and diabetes: a two-way relationship. Diabetologia.2012 Jan;55(1):21-31. doi: 10.1007/s00125-011-2342-y. Epub 2011 Nov 6.179. Pyörälä M, Miettinen H, Laakso M, Pyörälä K Hyperinsulinemia predictscoronary heart disease risk in healthy middle-aged men: the 22-year followup results of the Helsinki Policemen Study. Circulation. 1998 Aug 4;98(5):398-404].180. Razzouk L, Muntner P.
Ethnic, gender, and age-related differences in patientswith the metabolic syndrome. Curr Hypertens Rep. 2009 Apr;11(2):127-32.181. Reyes L, Herrera D, Kozarov E, Roldan S, Progulske-Fox A. Periodontalbacterial invasion and infection: contribution to atherosclerotic pathology. J.Clin. Periodontol.
2013; 40(Suppl 14):S30–50. [PubMed: 23627333]]182. Reynolds MA. Modifiable risk factors in periodontitis: at the intersection ofaginganddisease.Periodontol2000.2014Feb;64(1):7-19.doi:10.1111/prd.12047.183. Ridker PM. Evaluating novel cardiovascular risk factors: can we betterpredict heart attacks? Ann Intern Med 1999; 130: 933–937184.
Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW Creactive protein, the metabolic syndrome, and prediction of cardiovascularevents in the Framingham Offspring Study. Circulation. 2004 Jul27;110(4):380-5. Epub 2004 Jul 19. .;185. Sagalovsky S., Schönert M. RANKL-RANK-OPG system and boneremodeling: a new approach on the treatment of osteoporosis. // Clin. Exptl.Pathol. -2011.
-N2(10). –P.146-153.186. Sahingur SE, Sharma A, Genco RJ, De Nardin E J Association of increasedlevels of fibrinogen and the -455G/A fibrinogen gene polymorphism withchronic periodontitis. Periodontol. 2003 Mar; 74(3):329-37.187. Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontaldisease. Periodontol 2000. 2007;43:254-66.148188. Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley THJr, Kullo IJ Plasma carboxy-terminal provasopressin (copeptin): a novelmarker of insulin resistance and metabolic syndrome.
J Clin EndocrinolMetab. 2009 Jul; 94(7):2558-64.189. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationshipbetween periodontal infections and systemic disease. Clin Microbiol Infect.2007 Oct;13 Suppl 4:3-10. Review.190. Sfyroeras GS, Roussas N, Saleptsis VG, Argyriou C, Giannoukas AD.Association between periodontal disease and stroke. J Vasc Surg. 2012;55(4):1178–1184191. Shiau HJ, Reynolds MA.
Sex differences in destructive periodontal disease: asystematic review. J Periodontol. 2010;81:1379–1389. [PubMed].192. Shiau HJ, Reynolds MA. Sex differences in destructive periodontal disease:exploring the biologic basis. J Periodontol. 2010 Nov;81(11):1505-17. doi:10.1902/jop.2010.100045. Epub 2010 Jul 1.193. Shiau MY, Lu HF, Chang YH, Chiu YC, Shih YL Characterization ofproteins regulated by interleukin-4 in 3T3-L1 adipocytes.
Springerplus. 2015Jun 4;4:242. doi: 10.1186/s40064-015-0980-0. eCollection 2015.194. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H Theeffect of periodontal treatment on serum leptin, interleukin-6, and C-reactiveprotein. J Periodontol. 2010 Aug; 81(8):1118-23.195. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita YRelationship of metabolic syndrome to periodontal disease in Japanesewomen: the Hisayama Study. J Dent Res. 2007 Mar; 86(3):271-5.196.
Slocum C, et al. Distinct lipid A moieties contribute to pathogen-induced sitespecific vascular inflammation. PLoS Pathog. 2014; 10:e1004215. [PubMed:25010102]197. Sora ND, Marlow NM, Bandyopadhyay D, Leite RS, Slate EH, Fernandes JKMetabolic syndrome and periodontitis in Gullah African Americans with type1492 diabetes mellitus.
J Clin Periodontol. 2013 Jun;40(6):599-606. doi:10.1111/jcpe.12104. Epub 2013 Apr 5198. Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, TuomainenAM, Lauhio A, Pussinen PJ, Mäntylä P Collagenase-2 (MMP-8) as a pointof-care biomarker in periodontitis and cardiovascular diseases. Therapeuticresponse to non-antimicrobial properties of tetracyclines. Pharmacol Res.2011 Feb; 63(2):108-13199. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM Inflammatorycytokines, adiponectin, insulin resistance and metabolic control afterperiodontal intervention in patients with type 2 diabetes and chronicperiodontitis.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
